1. Mutation: Bacteria naturally undergo mutations in their DNA, which can lead to alterations in their proteins and other cellular structures. Some mutations can confer resistance to antimicrobial agents.
2. Selection and horizontal gene transfer: When bacteria are exposed to antimicrobial agents, the ones with resistance-conferring mutations have a selective advantage. They can survive and reproduce while susceptible bacteria are killed. Over time, the resistant bacteria become more prevalent within the bacterial population. Additionally, bacteria can acquire resistance genes from other bacteria through a process called horizontal gene transfer, which further contributes to the spread of antimicrobial resistance.
3. Persistence and environmental reservoirs: Once resistant bacteria emerge, they can persist in various environments, including hospitals, farms, and communities. They can survive on surfaces, in water, or within the bodies of humans and animals. These reservoirs serve as sources of resistant bacteria, facilitating their transmission and potential spread to new hosts.
4. Overuse and misuse of antimicrobial agents: The overuse and misuse of antimicrobial agents, such as antibiotics, contribute to the development and selection of resistant bacteria. When antimicrobial agents are used inappropriately or unnecessarily, they exert selective pressure that favors the survival and proliferation of resistant bacteria.
5. Limited treatment options: The emergence of antimicrobial resistance can lead to limited treatment options for bacterial infections. When bacteria become resistant to multiple antimicrobial agents, it becomes more challenging to effectively treat infections caused by them. This can result in prolonged illnesses, increased healthcare costs, and even higher mortality rates.
To address the problem of superbugs, it is crucial to implement strategies such as prudent use of antimicrobial agents, infection prevention and control measures, surveillance of antimicrobial resistance, and ongoing research and development of new antimicrobial agents and alternative treatment approaches.
